|
|
Noveris Health Sciences Inc
CSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/28/2026 15:59
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeCSE
Market Capitalization76.7 mln
Earnings Date08/17/2026
Relative Strength
15
/ 100
Significantly lagging
Key Fundamentals
EPS2.51
P/E0.48
ROIC-7.60
ROA302
EBITDA, mln1.82
EV / EBITDA59.37
EV / EBIT59.37
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
0% |
69
/ 100
 |
| 1 Month |
-35.29% |
12
/ 100
 |
| 2 Months |
-36.32% |
33
/ 100
 |
|
| |
